Home › All Companies › BGMSP › Current Report

Bio Green Med Solution, Inc. (BGMSP) — Current Report

AI-Powered SEC Filing Analysis

← All BGMSP filings
Latest Current Report Filed: 2026-05-14

Key Insights

  • Company issued Q1 2026 results on May 14, 2026, though the actual financial figures and performance metrics are not disclosed in this 8-K filing itself—the press release details are referenced but not included in the provided document.
  • Bio Green Med Solution is listed on Nasdaq Capital Market under ticker BGMS, indicating it meets minimum listing standards, though the company maintains operations in Malaysia with headquarters in Kuala Lumpur.
  • The filing is classified as non-material disclosure under Items 2.02 and 7.01, meaning the information is furnished but not 'filed' and thus not incorporated by reference into other SEC filings, limiting its legal significance.
  • Leadership is represented by Datuk Dr. Doris Wong Sing Ee as CEO and Executive Director, providing clarity on management accountability for reported results.
Sentiment: Neutral Significance: 3/10
View Original Filing →

Want the newest filings?

This analysis covers the filing from 2026-05-14. New 10-K, 10-Q and 8-K filings are analyzed the moment they are released — exclusively in the app.

Download on the App Store Open in app →

Earlier Current Report filings

Filed: 2026-04-13
  • Bio Green Med Solution, Inc. declared a quarterly cash dividend of $0.15 per share on its 6% Convertible Exchangeable Preferred Stock, indicating ongoing financial stability and shareholder returns.
  • The company's headquarters are located in Kuala Lumpur, Malaysia, suggesting potential international growth opportunities or operations.
  • Bio Green Med Solution, Inc. is a publicly traded company listed on the Nasdaq Capital Market, providing access to capital markets for potential investors.
Sentiment: Positive Significance: 5/10
View Original Filing →
Filed: 2026-03-30
  • Bio Green Med Solution, Inc. reported fourth quarter and full-year 2025 financial results, providing an update on the company's performance and outlook.
  • The company's revenue and earnings figures for Q4 2025 were disclosed, which investors can use to assess the company's recent financial performance.
  • The filing contains forward-looking statements about the company's future, which could provide insights into management's expectations and plans for the business.
Sentiment: Neutral Significance: 4/10
View Original Filing →
Filed: 2026-01-12
  • Bio Green Med Solution, Inc. declared a quarterly cash dividend of $0.15 per share on its 6% Convertible Exchangeable Preferred Stock, indicating financial stability and shareholder returns.
  • The company's preferred stock is listed on the Nasdaq Capital Market, providing access to public markets and potential liquidity for investors.
  • The filing does not mention any significant changes to the company's business, operations, or financial condition, suggesting a routine reporting event.
Sentiment: Positive Significance: 4/10
View Original Filing →

Other reports for Bio Green Med Solution, Inc.

Quarterly Report Annual Report

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.